Video Experimental Relacionado
Updated: Feb 22, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Anticoagulación, Trombosis Recurrente y Hemorragia Mayor en el Síndrome Antifosfolípido: Estudio Observacional
Christina Keshini Crossette-Thambiah1, Indika Rajakaruna2, Zain Odho3
1Imperial College London, London, United Kingdom.
El manejo del síndrome antifosfolípido (SAF) muestra altas tasas de trombosis recurrente a pesar de la anticoagulación. El anticoagulante lúpico y la trombosis arterial aumentan el riesgo de recurrencia, lo que resalta una estratificación del riesgo inadecuada para pacientes con SAF.
Videos de Conceptos Relacionados
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis IV: Nursing Management

